After losing out on big prospect, O’Neill’s Discovery Labs takes on cell-gene therapy manufacturing

Developer Brian O’Neill’s Discovery Labs in King of Prussia was one of two sites in Montgomery County that had made a list compiled by Eli Lilly & Co. in a nationwide search for 450,000 square feet of space for a production facility but the pharmaceutical company ultimately selected a location in Durham, North Carolina.

The announcement by Lilly was made on Jan. 21 and a day later, O’Neill announced he had teamed up with Deerfield Management Co. to launch the Center for Breakthrough Medicines in 680,000 square feet at Discovery Labs that will serve as a manufacturing facility for companies needing a place to outsource cell-and-gene therapy production. On Jan. 22, O’Neill and Tony Khoury, a board member of Discovery Labs and an engineer at Project Pharma, were speaking at the 2020 Phacilitate World Stem Cell Summit in Miami discussing the future of gene therapy manufacturing…

Read full story

Share with a Friend
Recent Press